DEFERASIROX: OVER A DECADE OF EXPERIENCE IN THALASSEMIA
Thalassemia incorporates a broad clinical spectrum characterized by decreased or absent production of normal hemoglobin leading to decreased red blood cell survival and ineffective erythropoiesis. Chronic iron overload remains an inevitable complication resulting from regular blood transfusions (tra...
Saved in:
| Main Author: | Ali Taher |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PAGEPress Publications
2018-11-01
|
| Series: | Mediterranean Journal of Hematology and Infectious Diseases |
| Subjects: | |
| Online Access: | https://www.mjhid.org/index.php/mjhid/article/view/3716 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hepatic iron overload in transfusion-dependent paediatric thalassemia (TDT) patients: association of magnetic resonance imaging with serum ferritin level
by: Anita Mehta, et al.
Published: (2025-07-01) -
LONG-TERM EFFECTIVENESS, SAFETY, AND TOLERABILITY OF TWICE-DAILY DOSING WITH DEFERASIROX IN CHILDREN WITH TRANSFUSION-DEPENDENT THALASSEMIAS UNRESPONSIVE TO STANDARD ONCE-DAILY DOSING
by: Jassada Buaboonnam, et al.
Published: (2021-10-01) -
Efficacy and safety of deferasirox in pediatric patients of thalassemia at a Tertiary Care Teaching Hospital
by: Dhaval R Thakor, et al.
Published: (2017-01-01) -
THE RELATION BETWEEN TYPES OF IRON CHELATORS AND FERITIN ON OSTEOCALCIN OF THALASSEMIA PATIENTS WITH REPEATED TRANSFUSIONS
by: Sesa Amelia, et al.
Published: (2020-01-01) -
Comparative Efficacy of Iron Chelation Therapies on Cardiac and Liver Iron Levels in Thalassemia Patients: A Systematic Review and Network Meta-Analysis
by: Abdulsalam Aleid, et al.
Published: (2024-10-01)